Attached files

file filename
8-K - FORM 8-K - RITE AID CORPrad_8k.htm

 
Exhibit 99.1


Press Release
For Further Information Contact:

INVESTORS:
MEDIA:
Matt Schroeder
Karen Rugen
(717) 214-8867
(717) 730-7766
or investor@riteaid.com

FOR IMMEDIATE RELEASE

RITE AID REPORTS THIRD QUARTER FISCAL 2011 RESULTS

·
Third Quarter Net Loss of $0.09 per Diluted Share Compared to Prior Third Quarter Net Loss of $0.10 per Diluted Share

·
Third Quarter Adjusted EBITDA of $212.5 Million Compared to Prior Third Quarter Adjusted EBITDA of $254.2 Million

·
Weaker Flu Season Negatively Impacted Pharmacy Sales by $50 Million

·
Continued Strong Liquidity of $966 Million at Quarter End

·
Rite Aid Lowers Fiscal 2011 Outlook

Camp Hill, PA (December 16, 2010)—Rite Aid Corporation (NYSE: RAD) today reported financial results for its third fiscal quarter ended November 27, 2010.

The company reported revenues of $6.2 billion, a net loss of $79.1 million or $0.09 per diluted share and Adjusted EBITDA of $212.5 million or 3.4 percent of revenues.  Negatively impacting results were a slower start to the cough, cold and flu season coupled with an increase in workers’ compensation and general liability self insurance expense.

“The quarter was below our expectations. While the lack of cough, cold and flu had a significant impact on our results, the good news is that our front end sales began to turn around during the quarter and our team continued to do a good job of controlling costs. We are pleased to see that our loyalty program wellness + continues to gain traction with customers and patients,” said John Standley, Rite Aid president and CEO.

“Based on our third quarter results and our current view that same stores sales in the fourth quarter will be softer than we had expected, we have lowered our guidance for the full year,” Standley said.

- MORE -
 
 
 

 


Rite Aid FY11 Q3 Press Release – page 2


Third Quarter Summary

Revenues for the 13-week quarter were $6.2 billion versus revenues of $6.4 billion in last year’s like period.  Revenues decreased 2.4 percent primarily as a result of a decline in pharmacy same store sales and store closings.

Same store sales for the quarter decreased 1.3 percent over the prior 13-week period, with flat front end sales and a 1.9 percent decrease in the pharmacy.  Pharmacy sales included an approximate 242 basis point negative impact from new generic introductions.  The number of prescriptions filled in comparable stores decreased 1.7 percent over the prior-year period, negatively impacted 1.3 percent by the lower incidence of cough, cold and flu.   Prescription sales accounted for 68.3 percent of total drugstore sales, and third party prescription revenue was 96.2 percent of pharmacy sales.

Net loss was $79.1 million or $0.09 per diluted share compared to last year’s third quarter net loss of $83.9 million or $0.10 per diluted share.  Lower lease termination and impairment charges, lower LIFO expense, lower interest and securitization expense and a reduction in depreciation and amortization helped offset the impact of the decline in Adjusted EBITDA on net loss.

Adjusted EBITDA (which is reconciled to net loss on the attached table) was $212.5 million or 3.4 percent of revenues for the third quarter compared to $254.2 million or 4.0 percent of revenues for the like period last year.  Adjusted EBITDA was negatively impacted by $12.0 million due to fewer cough, cold and flu prescriptions filled year over year and a $29.5 million increase in workers’ compensation and general liability self insurance expense.   The increase in self insurance expense is due to a reduction of reserves recorded in last year’s third quarter because of favorable claims experience.

In the third quarter, the company opened 1 new store, relocated 11 stores, remodeled 15 stores and closed 17 stores.  Stores in operation at the end of the quarter totaled 4,731.

Other Events During the Quarter

As previously announced, during the quarter Rite Aid added the Save-A-Lot discount, limited grocery assortment concept to 10 of its existing stores in the Greenville SC market after entering into a licensing agreement with Save-A-Lot, a SUPERVALU company. The stores are co-branded Save-A-Lot Food Stores/Rite Aid Pharmacy and are owned and operated by Rite Aid.

Rite Aid Lowers Fiscal 2011 Guidance

Based on its third quarter results and its lower expectation for same store sales in the fourth quarter, Rite Aid lowered its fiscal 2011 guidance for sales and Adjusted EBITDA and increased fiscal 2011 guidance for net loss.  Sales are now expected to be between $25.0 billion and $25.2 billion with same store sales expected to range from a decrease of 1.5 percent to a decrease of 0.9 percent. Adjusted EBITDA is expected to be between $815 million and $855 million. Net loss is expected to be between $655 million or $0.74 per diluted share and $525 million or $0.60 per diluted share.  Based upon current spending trends and expectations for the remainder of the year, the guidance for capital expenditures has been reduced to $215 million.

-MORE-
 
 
 

 
 
Rite Aid FY11 Q3 Press Release – page 3
 

Conference Call Broadcast

Rite Aid will hold an analyst call at 8:30 a.m. Eastern Time today with remarks by Rite Aid's management team.  The call will be simulcast via the internet and can be accessed through the websites www.riteaid.com in the conference call section of investor information and www.StreetEvents.com.  Slides related to materials discussed on the call will be available on both sites.  A playback of the call will be available on both sites starting at 12 p.m. Eastern Time today.  A playback of the call will also be available by telephone beginning at 12 p.m. Eastern Time today until 11:59 p.m. Eastern Time on December 18, 2010.  The playback number is 1-800-642-1687 from within the U.S. and Canada or 1-706-645-9291 from outside the U.S. and Canada with the eight-digit reservation number 29105610.

Rite Aid is one of the nation’s leading drugstore chains with more than 4,700 stores in 31 states and the District of Columbia with fiscal 2010 annual revenues of $25.7 billion.  Information about Rite Aid, including corporate background and press releases, is available through Rite Aid’s website at www.riteaid.com.

This press release contains forward-looking statements, including guidance, which are subject to certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied in such forward-looking statements include our high level of indebtedness; our ability to make interest and principal payments on our debt and satisfy the other covenants contained in our senior secured credit facility and other debt agreements; general economic conditions, including the impact of continued high unemployment and changing consumer behavior; inflation and interest rate movements; our ability to improve the operating performance of our stores in accordance with our long term strategy; our ability to realize same store sales growth; our ability to hire and retain qualified personnel; the efforts of private and public third-party payors to reduce prescription drug reimbursements and encourage mail order; competitive pricing pressures, including aggressive promotional activity from our competitors; decisions to close additional stores and distribution centers, which could result in further charges to our operating statement; our ability to manage expenses; our ability to realize the benefits from actions to further reduce costs and investment in working capital; continued consolidation of the drugstore industry; changes in state or federal legislation or regulations;  the outcome of lawsuits and governmental investigations and health care reform; and our ability to maintain the listing of our common stock on the New York Stock Exchange and the resulting impact to our indebtedness and financial condition.  Consequently, all of the forward-looking statements made in this press release, are qualified by these and other factors, risks and uncertainties. Readers are also directed to consider other risks and uncertainties discussed in documents filed by the Company with the Securities and Exchange Commission. Forward-looking statements can be identified through the use of words such as "may", "will", "intend", "plan", "project", "expect", "anticipate", "could", "should", "would", "believe", "estimate", "contemplate", and "possible".

See the attached table for a reconciliation of a non-GAAP financial measure, Adjusted EBITDA to net income (loss), the most comparable GAAP financial measure. We define Adjusted EBITDA as net income (loss) from operations excluding the impact of income taxes, interest expense and securitization costs, depreciation and amortization, LIFO adjustments, charges or credits for store closing and impairment, inventory write-downs related to closed stores, stock-based compensation expense, debt modifications and retirements, sale of assets and investments, revenue deferrals related to customer loyalty programs and other items.
 
# # #

 
 

 

RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED BALANCE SHEETS
 
(Dollars in thousands)
 
(unaudited)
 
   
   
November 27, 2010
   
February 27, 2010
 
ASSETS
           
Current assets:
           
Cash and cash equivalents
  $ 122,042     $ 103,594  
Accounts receivable, net
    974,472       955,502  
Inventories, net of LIFO reserve of $875,193 and $831,113
    3,330,805       3,238,644  
Prepaid expenses and other current assets
    100,037       210,928  
Total current assets
    4,527,356       4,508,668  
Property, plant and equipment, net
    2,138,540       2,293,153  
Other intangibles, net
    701,497       823,088  
Other assets
    448,575       425,002  
Total assets
  $ 7,815,968     $ 8,049,911  
                 
LIABILITIES AND STOCKHOLDERS' DEFICIT
               
Current liabilities:
               
Current maturities of long-term debt and lease financing obligations
  $ 34,248     $ 51,502  
Accounts payable
    1,292,350       1,159,069  
Accrued salaries, wages and other current liabilities
    1,107,235       965,121  
Total current liabilities
    2,433,833       2,175,692  
Long-term debt, less current maturities
    6,089,772       6,185,633  
Lease financing obligations, less current maturities
    125,074       133,764  
Other noncurrent liabilities
    1,175,505       1,228,373  
Total liabilities
    9,824,184       9,723,462  
                 
Commitments and contingencies
    -       -  
Stockholders' deficit:
               
Preferred stock - Series G
    1       1  
Preferred stock - Series H
    159,261       152,304  
Common stock
    890,322       887,636  
Additional paid-in capital
    4,280,455       4,277,200  
Accumulated deficit
    (7,309,103 )     (6,959,372 )
Accumulated other comprehensive loss
    (29,152 )     (31,320 )
Total stockholders' deficit
    (2,008,216 )     (1,673,551 )
Total liabilities and stockholders' deficit
  $ 7,815,968     $ 8,049,911  

Chart 1

 
 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED STATEMENTS OF OPERATIONS
 
(Dollars in thousands, except per share amounts)
 
(unaudited)
 
   
   
   
Thirteen weeks ended November 27, 2010
   
Thirteen weeks ended November 28, 2009
 
Revenues
  $ 6,202,353     $ 6,352,283  
Costs and expenses:
               
Cost of goods sold
    4,561,200       4,665,871  
Selling, general and administrative expenses
    1,578,142       1,605,213  
Lease termination and impairment charges
    17,003       35,072  
Interest expense
    133,742       135,770  
Gain on sale of assets, net
    (7,050 )     (1,459 )
                 
      6,283,037       6,440,467  
                 
Loss before income taxes
    (80,684 )     (88,184 )
Income tax benefit
    (1,613 )     (4,322 )
Net loss
  $ (79,071 )   $ (83,862 )
                 
Basic and diluted loss per share:
               
                 
Numerator for loss per share:
               
Net loss
  $ (79,071 )   $ (83,862 )
Accretion of redeemable preferred stock
    (26 )     (26 )
Cumulative preferred stock dividends
    (2,354 )     (2,218 )
Loss attributable to common stockholders - basic and diluted
  $ (81,451 )   $ (86,106 )
                 
                 
                 
Basic and diluted weighted average shares
    883,515       881,371  
                 
Basic and diluted loss per share
  $ (0.09 )   $ (0.10 )
 
Chart 2

 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED STATEMENTS OF OPERATIONS
 
(Dollars in thousands, except per share amounts)
 
(unaudited)
 
   
   
   
Thirty-nine weeks ended November 27, 2010
   
Thirty-nine weeks ended November 28, 2009
 
Revenues
  $ 18,758,441     $ 19,205,331  
Costs and expenses:
               
Cost of goods sold
    13,766,924       14,056,578  
Selling, general and administrative expenses
    4,827,780       4,961,798  
Lease termination and impairment charges
    56,820       130,810  
Interest expense
    415,077       374,076  
Loss on debt modifications and retirements, net
    44,003       993  
Gain on sale of assets, net
    (10,786 )     (25,598 )
                 
      19,099,818       19,498,657  
                 
Loss before income taxes
    (341,377 )     (293,326 )
Income tax expense
    8,354       4,994  
Net loss
  $ (349,731 )   $ (298,320 )
                 
Basic and diluted loss per share:
               
                 
Numerator for loss per share:
               
Net loss
  $ (349,731 )   $ (298,320 )
Accretion of redeemable preferred stock
    (77 )     (77 )
Cumulative preferred stock dividends
    (6,957 )     (6,556 )
Loss attributable to common stockholders - basic and diluted
  $ (356,765 )   $ (304,953 )
                 
                 
                 
Basic and diluted weighted average shares
    882,668       880,577  
                 
Basic and diluted loss per share
  $ (0.40 )   $ (0.35 )

Chart 3

 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
   
SUPPLEMENTAL OPERATING AND CASH FLOW INFORMATION
 
(Dollars in thousands, except per share amounts)
 
(unaudited)
 
   
   
   
Thirteen weeks ended November 27, 2010
   
Thirteen weeks ended November 28, 2009
 
             
SUPPLEMENTAL OPERATING INFORMATION
           
             
Revenues
  $ 6,202,353     $ 6,352,283  
Cost of goods sold
    4,561,200       4,665,871  
Gross profit
    1,641,153       1,686,412  
LIFO charge
    3,024       14,770  
FIFO gross profit
    1,644,177       1,701,182  
                 
Gross profit as a percentage of revenues
    26.46%       26.55%  
LIFO charge as a percentage of revenues
    0.05%       0.23%  
FIFO gross profit as a percentage of revenues
    26.51%       26.78%  
                 
Selling, general and administrative expenses
    1,578,142       1,605,213  
Selling, general and administrative expenses as a percentage of revenues
    25.44%       25.27%  
                 
Cash interest expense
    123,489       124,495  
Non-cash interest expense
    10,253       11,275  
Total interest expense
    133,742       135,770  
Securitization costs (included in SG&A)
    -       8,362  
Total interest expense and securitization costs
    133,742       144,132  
                 
                 
Adjusted EBITDA
    212,499       254,192  
Adjusted EBITDA as a percentage of revenues
    3.43%       4.00%  
                 
Net loss
    (79,071 )     (83,862 )
Net loss as a percentage of revenues
    -1.27%       -1.32%  
                 
Total debt
    6,249,094       6,421,643  
Invested cash
    1,371       21,209  
Total debt net of invested cash
    6,247,723       6,400,434  
                 
                 
SUPPLEMENTAL CASH FLOW INFORMATION
               
                 
Payments for property, plant and equipment
    31,864       43,342  
Intangible assets acquired
    5,849       2,214  
Total cash capital expenditures
    37,713       45,556  
Equipment received for noncash consideration
    222       1,612  
Equipment financed under capital leases
    772       -  
Gross capital expenditures
  $ 38,707     $ 47,168  
 
Chart 4

 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
   
SUPPLEMENTAL OPERATING AND CASH FLOW INFORMATION
 
(Dollars in thousands, except per share amounts)
 
(unaudited)
 
   
   
   
Thirty-nine weeks ended November 27, 2010
   
Thirty-nine weeks ended November 28, 2009
 
             
SUPPLEMENTAL OPERATING INFORMATION
           
             
Revenues
  $ 18,758,441     $ 19,205,331  
Cost of goods sold
    13,766,924       14,056,578  
Gross profit
    4,991,517       5,148,753  
LIFO charge
    44,080       44,310  
FIFO gross profit
    5,035,597       5,193,063  
                 
Gross profit as a percentage of revenues
    26.61%       26.81%  
LIFO charge as a percentage of revenues
    0.23%       0.23%  
FIFO gross profit as a percentage of revenues
    26.84%       27.04%  
                 
Selling, general and administrative expenses
    4,827,780       4,961,798  
Selling, general and administrative expenses as a percentage of revenues
    25.74%       25.84%  
                 
Cash interest expense
    381,442       345,079  
Non-cash interest expense
    33,635       28,997  
Total interest expense
    415,077       374,076  
Securitization costs (included in SG&A)
    -       36,862  
Total interest expense and securitization costs
    415,077       410,938  
                 
                 
Adjusted EBITDA
    643,533       719,923  
Adjusted EBITDA as a percentage of revenues
    3.43%       3.75%  
                 
Net loss
    (349,731 )     (298,320 )
Net loss as a percentage of revenues
    -1.86%       -1.55%  
                 
Total debt
    6,249,094       6,421,643  
Invested cash
    1,371       21,209  
Total debt net of invested cash
    6,247,723       6,400,434  
                 
                 
SUPPLEMENTAL CASH FLOW INFORMATION
               
                 
Payments for property, plant and equipment
    104,383       124,541  
Intangible assets acquired
    16,071       5,661  
Total cash capital expenditures
    120,454       130,202  
Equipment received for noncash consideration
    2,428       9,450  
Equipment financed under capital leases
    2,836       185  
Gross capital expenditures
  $ 125,718     $ 139,837  
 
Chart 5

 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
SUPPLEMENTAL INFORMATION
 
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
 
(In thousands)
 
   
   
   
Thirteen weeks ended November 27, 2010
   
Thirteen weeks ended November 28, 2009
 
             
             
Reconciliation of net loss to adjusted EBITDA:
           
Net loss
  $ (79,071 )   $ (83,862 )
Adjustments:
               
Interest expense and securitization costs
    133,742       144,132  
Income tax benefit
    (1,613 )     (4,322 )
Depreciation and amortization
    124,985       132,547  
LIFO charges
    3,024       14,770  
Lease termination and impairment charges
    17,003       35,072  
Stock-based compensation expense
    4,167       5,826  
Gain on sale of assets, net
    (7,050 )     (1,459 )
Closed facility liquidation expense
    2,386       4,445  
Severance costs
    2,019       135  
Customer loyalty card programs revenue deferral (a)
    13,807       -  
Other
    (900 )     6,908  
Adjusted EBITDA
  $ 212,499     $ 254,192  
Percent of revenues
    3.43%       4.00%  

Notes:
 
(a)  Relates to deferral of revenues for our customer loyalty programs.
 
Chart 6


 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
SUPPLEMENTAL INFORMATION
 
RECONCILIATION OF NET LOSS TO ADJUSTED EBITDA
 
(In thousands)
 
   
   
   
Thirty-nine weeks ended November 27, 2010
   
Thirty-nine weeks ended November 28, 2009
 
             
             
Reconciliation of net loss to adjusted EBITDA:
           
Net loss
  $ (349,731 )   $ (298,320 )
Adjustments:
               
Interest expense and securitization costs
    415,077       410,938  
Income tax expense
    8,354       4,994  
Depreciation and amortization
    378,998       404,307  
LIFO charges
    44,080       44,310  
Lease termination and impairment charges
    56,820       130,810  
Stock-based compensation expense
    13,902       18,335  
Gain on sale of assets, net
    (10,786 )     (25,598 )
Loss on debt modifications and retirements, net
    44,003       993  
Closed facility liquidation expense
    6,619       13,253  
Severance costs
    2,029       6,184  
Customer loyalty card programs revenue deferral (a)
    34,238       -  
Other
    (70 )     9,717  
Adjusted EBITDA
  $ 643,533     $ 719,923  
Percent of revenues
    3.43%       3.75%  

Notes:
 
(a)  Relates to deferral of revenues for our customer loyalty programs.
 
Chart 7
 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(Dollars in thousands)
 
(unaudited)
 
   
   
   
   
Thirteen weeks ended November 27, 2010
   
Thirteen weeks ended November 28, 2009
 
             
             
 OPERATING ACTIVITIES:
           
 Net loss
  $ (79,071 )   $ (83,862 )
 Adjustments to reconcile to net cash used in operating activities:
               
 Depreciation and amortization
    124,985       132,547  
 Lease termination and impairment charges
    17,003       35,072  
 LIFO charges
    3,024       14,770  
 Gain on sale of assets, net
    (7,050 )     (1,459 )
 Stock-based compensation expense
    4,167       5,826  
 Changes in operating assets and liabilities:
               
 Net repayments to accounts receivable securitization
    -       (400,000 )
 Accounts receivable
    (27,633 )     (65,332 )
 Inventories
    (76,330 )     (166,340 )
 Accounts payable
    (38,648 )     91,643  
 Other assets and liabilities, net
    33,146       2,084  
 Net cash used in operating activities
    (46,407 )     (435,051 )
 INVESTING ACTIVITIES:
               
 Payments for property, plant and equipment
    (31,864 )     (43,342 )
 Intangible assets acquired
    (5,849 )     (2,214 )
 Proceeds from dispositions of assets and investments
    8,345       3,510  
 Net cash used in investing activities
    (29,368 )     (42,046 )
 FINANCING ACTIVITIES:
               
 Proceeds from issuance of long-term debt
    -       396,703  
 Net proceeds from revolver
    58,000       124,000  
 Principal payments on long-term debt
    (6,147 )     (7,284 )
 Change in zero balance cash accounts
    13,789       13,448  
 Net proceeds from the issuance of common stock
    7       30  
 Deferred financing costs paid
    (244 )     (14,178 )
 Net cash provided by financing activities
    65,405       512,719  
 (Decrease) increase in cash and cash equivalents
    (10,370 )     35,622  
 Cash and cash equivalents, beginning of period
    132,412       121,007  
 Cash and cash equivalents, end of period
  $ 122,042     $ 156,629  
 
Chart 8

 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
   
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
(Dollars in thousands)
 
(unaudited)
 
   
   
   
   
Thirty-nine weeks ended November 27, 2010
   
Thirty-nine weeks ended November 28, 2009
 
             
             
 OPERATING ACTIVITIES:
           
 Net loss
  $ (349,731 )   $ (298,320 )
 Adjustments to reconcile to net cash provided by (used in) operating activities:
               
 Depreciation and amortization
    378,998       404,307  
 Lease termination and impairment charges
    56,820       130,810  
 LIFO charges
    44,080       44,310  
 Gain on sale of assets, net
    (10,786 )     (25,598 )
 Stock-based compensation expense
    13,902       18,335  
 Loss on debt modification and retirements, net
    44,003       993  
 Proceeds from insured loss
    -       1,380  
 Changes in operating assets and liabilities:
               
 Net repayments to accounts receivable securitization
    -       (555,000 )
 Accounts receivable
    (18,970 )     (8,446 )
 Inventories
    (136,496 )     (111,301 )
 Accounts payable
    272,730       128,646  
 Other assets and liabilities, net
    172,852       45,575  
 Net cash provided by (used in) operating activities
    467,402       (224,309 )
 INVESTING ACTIVITIES:
               
 Payments for property, plant and equipment
    (104,383 )     (124,541 )
 Intangible assets acquired
    (16,071 )     (5,661 )
 Proceeds from sale-leaseback transactions
    -       6,532  
 Proceeds from dispositions of assets and investments
    17,266       39,208  
 Net cash used in investing activities
    (103,188 )     (84,462 )
 FINANCING ACTIVITIES:
               
 Proceeds from issuance of long-term debt
    650,000       1,303,307  
 Net repayments to revolver
    (22,000 )     (714,000 )
 Principal payments on long-term debt
    (775,236 )     (167,174 )
 Change in zero balance cash accounts
    (144,693 )     (49,475 )
 Net proceeds from the issuance of common stock
    101       30  
 Financing fees paid for early debt redemption
    (19,666 )     -  
 Deferred financing costs paid
    (34,272 )     (59,323 )
 Net cash (used in) provided by financing activities
    (345,766 )     313,365  
 Increase in cash and cash equivalents
    18,448       4,594  
 Cash and cash equivalents, beginning of period
    103,594       152,035  
 Cash and cash equivalents, end of period
  $ 122,042     $ 156,629  
 
Chart 9

 
 

 


RITE AID CORPORATION AND SUBSIDIARIES
 
SUPPLEMENTAL INFORMATION
 
RECONCILIATION OF NET LOSS GUIDANCE TO ADJUSTED EBITDA GUIDANCE
 
YEAR ENDING FEBRUARY 26, 2011
 
(In thousands, except per share amounts)
 
   
   
   
Guidance Range
 
   
Low
   
High
 
             
Sales
  $ 25,000,000     $ 25,150,000  
                 
Same store sales
    -1.50%       -0.90%  
                 
Gross capital expenditures
  $ 215,000     $ 215,000  
                 
Reconciliation of net loss to adjusted EBITDA:
               
Net loss
  $ (655,000 )   $ (525,000 )
Adjustments:
               
Interest expense
    560,000       550,000  
Income tax expense
    20,000       15,000  
Depreciation and amortization
    505,000       495,000  
LIFO charge
    70,000       60,000  
Store closing, liquidation, and impairment charges
    200,000       160,000  
Stock-based compensation expense
    20,000       15,000  
Customer loyalty card programs revenue deferral (a)
    50,000       40,000  
Loss on debt modification
    45,000       45,000  
Other
    -       -  
Adjusted EBITDA
  $ 815,000     $ 855,000  
                 
                 
Diluted loss per share
  $ (0.74 )   $ (0.60 )

(a) Relates to deferral of revenues for our customer loyalty programs.
 
Chart 10